日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial

出院时口服抗凝治疗协调（COACHeD）：试点随机对照试验

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-079353
Holbrook, Anne; Troyan, Sue; Telford, Victoria; Koubaesh, Yousery; Vidug, Kristina; Yoo, Lindsay; Deng, Jiawen; Lohit, Simran; Giilck, Stephen; Ahmed, Amna; Talman, Marianne; Leonard, Blair; Refaei, Mohammad; Tarride, Jean-Eric; Schulman, Sam; Douketis, James; Thabane, Lehana; Hyland, Sylvia; Ho, Joanne Man-Wai; Siegal, Deborah
发表日期：2024
文献求助 收藏

Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose-Response Meta-analysis

高剂量与低剂量皮质类固醇治疗重症至危重症 COVID-19：系统评价和剂量反应荟萃分析

期刊:Annals of the American Thoracic Society
影响因子:5.4
doi:10.1513/AnnalsATS.202208-720OC
Pitre, Tyler; Su, Johnny; Mah, Jasmine; Helmeczi, Wryan; Danho, Sharef; Plaxton, William; Giilck, Stephen; Rochwerg, Bram; Zeraatkar, Dena
发表日期：2023
文献求助 收藏

Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients

曲妥珠单抗时代HER2阳性早期乳腺癌患者的预后：一项基于加拿大患者的人群研究

期刊:Current Oncology
影响因子:3.4
doi:10.3747/co.20.1523
Zurawska, U; Baribeau, D A; Giilck, S; Victor, C; Gandhi, S; Florescu, A; Verma, S
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2013
文献求助 收藏